LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway.

Rochelson, Burton / Dowling, Oonagh / Schwartz, Nadav / Metz, Christine N

Journal of reproductive immunology

2006  Volume 73, Issue 2, Page(s) 101–107

Abstract: ... on human umbilical vein endothelial cell (HuVEC) inflammatory responses in vitro. HuVECs isolated from term umbilical cords were incubated ... a condition commonly treated with the tocolytic agent, magnesium sulfate (MgSO(4)). Based on recent findings ... activation. Endothelial cell supernatants were assayed for inflammatory mediator production (interleukin-8 ...

Abstract Dysfunctional endothelial cell activation and cytokines are implicated in preterm labor, a condition commonly treated with the tocolytic agent, magnesium sulfate (MgSO(4)). Based on recent findings showing the inflammatory effects of magnesium deficiency, we examined the effect of MgSO(4) on human umbilical vein endothelial cell (HuVEC) inflammatory responses in vitro. HuVECs isolated from term umbilical cords were incubated with MgSO(4) prior to stimulation with lipopolysaccharide (LPS) and then assessed for endothelial cell activation. Endothelial cell supernatants were assayed for inflammatory mediator production (interleukin-8; IL-8), and endothelial cell-associated intercellular adhesion molecule (ICAM-1) expression was determined. In the absence of LPS stimulation, MgSO(4) had no effect on HuVEC responses. Treatment of HuVECs with MgSO(4) prior to LPS stimulation inhibited inflammatory mediator production (p<0.05) and cell adhesion molecule expression (p<0.05) in a dose-dependent manner. Mechanistic studies showed that MgSO(4) reduced NFkappaB nuclear translocation and protected cytoplasmic IkappaBalpha from degradation in LPS-treated HuVECs. In conclusion, MgSO(4) inhibits endothelial cell activation, as measured by levels of IL-8 and ICAM-1 expression, via NFkappaB. Our results support the hypothesis that MgSO(4) treatment may function as an anti-inflammatory agent during preterm labor.
MeSH term(s) Active Transport, Cell Nucleus/drug effects ; Active Transport, Cell Nucleus/immunology ; Cell Adhesion/drug effects ; Cell Adhesion/immunology ; Cell Nucleus/immunology ; Cells, Cultured ; Endothelial Cells/immunology ; Endothelial Cells/pathology ; Female ; Humans ; I-kappa B Proteins/immunology ; Inflammation/immunology ; Inflammation/pathology ; Inflammation Mediators/immunology ; Intercellular Adhesion Molecule-1/immunology ; Interleukin-8/immunology ; Lipopolysaccharides/pharmacology ; Magnesium Sulfate/pharmacology ; NF-KappaB Inhibitor alpha ; NF-kappa B/immunology ; Pregnancy ; Premature Birth/immunology ; Premature Birth/pathology ; Tocolytic Agents/pharmacology ; Umbilical Veins/immunology ; Umbilical Veins/pathology
Chemical Substances CXCL8 protein, human ; I-kappa B Proteins ; Inflammation Mediators ; Interleukin-8 ; Lipopolysaccharides ; NF-kappa B ; NFKBIA protein, human ; Tocolytic Agents ; Intercellular Adhesion Molecule-1 (126547-89-5) ; NF-KappaB Inhibitor alpha (139874-52-5) ; Magnesium Sulfate (7487-88-9)
Language English
Publishing date 2006-09-06
Publishing country Ireland
Document type Journal Article
ZDB-ID 424421-7
ISSN 1872-7603 ; 0165-0378
ISSN (online) 1872-7603
ISSN 0165-0378
DOI 10.1016/j.jri.2006.06.004
Shelf mark
Zs.A 1483: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top